6 Papers
1 Citations
Mark Nyanzu is an academic researcher from First Affiliated Hospital of Wenzhou Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
VX765 Attenuates Pyroptosis and HMGB1/TLR4/NF-κB Pathways to Improve Functional Outcomes in TBI Mice
Zhezhe Sun,Mark Nyanzu,Su Yang,Xiaohong Zhu,Kankai Wang,Junnan Ru,Enxing Yu,Hengli Zhang,Zhenzhong Wang,Jie Shen,Qichuan Zhuge,Lijie Huang +11 more
TL;DR: VX765 can counteract neurological damage after TBI by reducing pyroptosis and HMGB1/TLR4/NF-κB pathway activities, and decreasing blood-brain barrier leakage, apoptosis, and microglia polarization to exhibit its neuroprotective effects.
95
Nanomaterial applications for neurological diseases and central nervous system injury.
Lijie Huang,Jiangnan Hu,Shengwei Huang,Brian Wang,Felix Siaw-Debrah,Mark Nyanzu,Yu Zhang,Qichuan Zhuge,Qichuan Zhuge +8 more
TL;DR: This review highlights the applications of nanomaterials in the developing neurological field and discusses the evidence for their efficacies.
58
Spontaneous resorption of giant serpentine aneurysm arising from middle cerebral artery.
TL;DR: A 38-year-old woman was admitted to the authors' department with a history of intermittent severe headaches accompanied by nausea and vomiting and was suspected to be a tumor accompanied by hemorrhage, and a giant MCA aneurysm was identified after the exposure of the lesion.
1